Allarity Therapeutics, Inc. (ALLR) vs Estrella Immunopharma, Inc. (ESLA)
A side-by-side comparison of Allarity Therapeutics, Inc. and Estrella Immunopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALLR
Allarity Therapeutics, Inc.
$1.00HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
ESLA
Estrella Immunopharma, Inc.
$0.44HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ALLR vs ESLA
growth of $100 · dividends reinvested · last 5yALLR -100.0% (-95.9%/yr)ESLA -95.5% (-46.3%/yr)ESLA compounded faster over this window
Log scale — wide-divergence pair
ALLR ESLA
ALLR vs ESLA: by the numbers
- •ESLA is the larger company ($19M vs $16M market cap).
- •Both run net losses; ESLA's is the smaller (0.00% vs -3575.07% net margin).
Metrics side by side
Valuation
| Metric | ALLR | ESLA |
|---|---|---|
| P/S ratio | 46.12 | N/A |
| P/B ratio | 4.50 | N/A |
Profitability
| Metric | ALLR | ESLA |
|---|---|---|
| Gross margin | 107.54% | 0.00% |
| Operating margin | -3939.06% | 0.00% |
| Net margin | -3575.07% | 0.00% |
| ROE | -348.81% | N/A |
| ROIC | -41.81% | N/A |
Growth (annualized)
| Metric | ALLR | ESLA |
|---|---|---|
| Total return CAGR (5Y) | N/A | -46.34% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.